1. Home
  2. JKS vs NVAX Comparison

JKS vs NVAX Comparison

Compare JKS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$21.35

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.68

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JKS
NVAX
Founded
2006
1987
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
JKS
NVAX
Price
$21.35
$8.68
Analyst Decision
Hold
Hold
Analyst Count
4
9
Target Price
$25.25
$11.33
AVG Volume (30 Days)
463.3K
3.3M
Earning Date
04-16-2026
05-07-2026
Dividend Yield
5.37%
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.42
N/A
P/E Ratio
N/A
$3.37
Revenue Growth
N/A
64.69
52 Week Low
$15.55
$5.80
52 Week High
$31.88
$11.85

Technical Indicators

Market Signals
Indicator
JKS
NVAX
Relative Strength Index (RSI) 33.33 48.46
Support Level N/A $8.01
Resistance Level $26.33 $9.05
Average True Range (ATR) 1.13 0.40
MACD -0.17 0.05
Stochastic Oscillator 17.01 79.50

Price Performance

Historical Comparison
JKS
NVAX

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: